XRP Healthcare, a rapidly growing innovator in AI-driven healthcare and mergers & acquisitions, has announced plans to go public by Q3 2025. The company has accelerated its initial public offering (IPO) timeline, moving its listing date from 2027 to the third quarter of this year on a Canadian stock exchange.
This strategic move aims to fast-track expansion, unlock new investment opportunities, and solidify XRP Healthcare’s position as a global leader in healthcare transformation. The decision follows a series of high-impact developments, including the acquisition of Pharma Ville, a pharmacy chain with five wholesale and two retail locations across Uganda.
Abraham Cinta, CEO of ARC Group, highlighted the significance of this milestone, stating in an exclusive interview featured in XRP Healthcare’s Special Edition Magazine that being in the spotlight could exponentially transform the company’s business, potentially by a factor of 10 or even 100.
The Pharma Ville acquisition grants XRP Healthcare direct access to vital pharmaceutical and medical infrastructure, strengthening its foothold in Africa’s projected USD 259 billion healthcare market. The IPO process is being guided by ARC Group, a globally recognized capital markets advisory firm.
According to Charles Chong, Vice President of EMEA Capital Markets at ARC Group, the listing in Canada is only the beginning since the long-term strategy includes securing a U.S. listing within five years to enhance investor exposure and global market visibility.
Supporting its vision for accessible healthcare, XRP Healthcare has launched the XRPH AI App, a global multilingual digital health assistant available on the Google Play Store and Apple App Store. The app provides AI-generated medical guidance, localized in multiple languages, making it a vital tool in regions with limited healthcare infrastructure.
Recent updates include an image upload feature for AI-assisted analysis of visible symptoms such as rashes, swelling, and fungal infections. A “Doctor Search & Connect” feature, set to launch next quarter, will allow users to connect with licensed medical professionals in their area.
By bridging healthcare access gaps, the XRPH AI App positions XRP Healthcare at the forefront of consumer-driven digital health innovation.
Whitney Lynn, Chairman of XRP Healthcare, who brings over 45 years of M&A experience with over $10 billion in value creation, emphasized the company is at a pivotal moment
toward becoming a publicly listed company before September. This is evidenced by the accelerated M&A strategy starting with the acquisition of the Pharma Ville pharmacy chain in Uganda.
Africa-Focused Growth Strategy
With trademark protection secured in the United Kingdom, European Union, UAE, and Uganda, XRP Healthcare is building a recognizable and defensible brand in digital healthcare. Laban Roomes, COO, described Pharma Ville as a strategic cornerstone in the company’s IPO acceleration, emphasizing that the five wholesale and two retail pharmacies in Uganda mark just the beginning.
XRP Healthcare’s rapid expansion model is well suited for Africa, where 57% of Uganda’s 46 million people rely on private healthcare providers, with over 6,000 fragmented operators in the market.
“We’ve laid the foundation for scale and are on track to list before autumn, unlocking capital to drive regional expansion and transform healthcare delivery across Africa,” said Laban Roomes.
Kain Roomes, CEO of XRP Healthcare, further emphasized the significance of consolidating and modernizing Africa’s private healthcare sector, which accounts for 50% of total service delivery.
“The IPO allows us to accelerate our mission and strengthen healthcare access and quality across the continent.”
Looking ahead, XRP Healthcare plans to expand into Kenya and Rwanda, leveraging the legal, operational, and regulatory frameworks already established in Uganda.
XRP Healthcare Moves IPO to Q3 2025, Fast-Tracking AI and M&A Global Expansion
Key Partnerships and AI-Driven Healthcare Innovation
Following the Pharma Ville acquisition, XRP Healthcare has forged partnerships with leading pharmaceutical and healthcare providers to enhance distribution and operations across Africa. These partnerships include:
- Incepta Pharmaceuticals – Generics and vaccines
- Ascensia Diabetes Care – Diabetes management solutions
- Universal Corporation – Global supplier of leaf tobacco for medical applications
- Naari – Women’s health pharmaceuticals
- Amanta Healthcare – Sterile injectables and IV infusions
- Marie Stopes Uganda – Reproductive health and family planning
- Medrull – Wound care and first-aid solutions
- Toros Group – High-quality pharmaceutical distribution
Additionally, XRP Healthcare has secured an exclusive distribution agreement across Africa with Isansys Lifecare, led by CTO Keith Errey, for the deployment of the Patient Status Engine (PSE). This fully wireless, AI-powered medical platform integrates advanced sensors, deep learning, and predictive analytics to enable earlier interventions, home-based care, and paperless hospital wards. The PSE is expected to revolutionize healthcare delivery by reducing pressure on hospitals and medical staff.
